Related Experiment Video

Updated: Jun 1, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.1K

Insights into tumor-derived exosome inhibition in cancer therapy

Ziwei Tang1, Cheng Chen1, Chen Zhou2

  • 1School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

European Journal of Medicinal Chemistry
|January 17, 2025
PubMed

Insights

Tumor-derived exosomes (TDEs) promote cancer progression and resistance. Inhibiting TDEs offers a promising cancer treatment strategy by targeting their biogenesis and secretion pathways.

Area of Science:

  • Cell biology
  • Cancer research
  • Biochemistry

Background:

  • Exosomes mediate cell-to-cell communication.
  • Tumor-derived exosomes (TDEs) drive cancer progression, metastasis, immune escape, and drug resistance.
  • Inhibiting TDEs is a potential cancer therapy strategy.

Purpose of the Study:

  • To review TDE biogenesis and secretion mechanisms.
  • To discuss small-molecule TDE inhibitors for cancer treatment.
  • To identify obstacles and solutions for TDE inhibitor development.

Main Methods:

  • Literature review of TDE biogenesis and secretion pathways.
  • Analysis of small-molecule TDE inhibitors targeting these pathways.
  • Discussion of challenges and future directions in TDE inhibitor research.

Main Results:

  • TDEs contribute significantly to tumorigenesis and cancer progression.
  • Small-molecule inhibitors targeting TDE biogenesis/secretion pathways show therapeutic potential.
  • Several obstacles hinder the clinical development of TDE inhibitors.

Conclusions:

  • Understanding TDE mechanisms is crucial for developing effective cancer therapies.
  • Targeting TDEs offers a novel approach to combat cancer.
  • Further research is needed to overcome challenges in TDE inhibitor development.
Keywords:
Cancer treatmentDrug resistanceExosomeSmall molecule inhibitorTumor microenvironment

More Related Videos

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.3K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K